세계의 호흡기 융합 바이러스 (RSV) 치료제 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측

Globalinforesearch 회사가 출판한 조사자료로, 코드는 GIR-AC0862 입니다.■ 상품코드 : GIR-AC0862
■ 조사/발행회사 : Globalinforesearch
■ 발행일 : 2019년 1월 11일
■ 페이지수 : 106
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품, 의료
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,480 ⇒환산₩3,828,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,220 ⇒환산₩5,742,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD6,960 ⇒환산₩7,656,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 호흡기 융합 바이러스 (RSV) 치료제의 세계시장에 대해서 조사분석한 자료로서, 호흡기 융합 바이러스 (RSV) 치료제의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다.
・세계의 호흡기 융합 바이러스 (RSV) 치료제시장동향
・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율)
・주요 지역별 호흡기 융합 바이러스 (RSV) 치료제 시장분석/시장규모
  - 북미시장 (미국, 캐나다, 멕시코)
  - 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아)
  - 아시아시장 (중국, 일본, 한국, 인도, 동남아시아)
  - 남미시장 (브라질, 아르헨티나, 콜롬비아)
  - 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카)
・호흡기 융합 바이러스 (RSV) 치료제의 종류별 시장분석/시장규모
・호흡기 융합 바이러스 (RSV) 치료제의 용도별 시장분석/시장규모
・호흡기 융합 바이러스 (RSV) 치료제의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측)
・호흡기 융합 바이러스 (RSV) 치료제의 판매채널, 유통업체 분석
...
■ 보고서 개요

Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital malformations of the airway. Treatment is limited to supportive care, including oxygen therapy and more advanced breathing support with CPAP or nasal high flow oxygen.

Scope of the Report:
This report focuses on the Human Respiratory Syncytial Virus Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One trend in the market is emergence of new entrants likely to change market dynamics. The growing demand for novel products for the treatment of RSV has fueled the emergence of new entrants that are likely to change the market dynamics during the forecast period. 
The active participation of emerging economies toward research and development will drive the growth prospects for the market during the forecast period. The increasing R&D activities in emerging economies for RSV infection and its causes will fuel the development of novel drugs. One of the major factors responsible for the market’s growth is the rising amount of patented therapies for RSV treatment that result in substantial R&D activities from various big pharma companies and research institutes. For instance, in June 2016, the Lancet Respiratory Medicine reported that RSV was the most commonly detected pathogen linked with pneumonia among children in South Africa. Such new findings will increase the scope of anti-RSV drugs in new applications, such as pneumonia.
ROW accounted for the maximum market share during 2017 and continue to dominate the market for the next few years. One of the major factors responsible for the market’s growth in the region is the growing incidence of RSV infections in ROW, including the BRIC nations.
The worldwide market for Human Respiratory Syncytial Virus Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
AstraZeneca
AbbVie
GSK
Teva Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Approved Drugs
Off-Label Drugs

Market Segment by Applications, can be divided into
Clinical Diagnostic
Laboratories Physicians’ Office
Laboratories Hospitals

There are 15 Chapters to deeply display the global Human Respiratory Syncytial Virus Drugs market.
Chapter 1, to describe Human Respiratory Syncytial Virus Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Respiratory Syncytial Virus Drugs, with sales, revenue, and price of Human Respiratory Syncytial Virus Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Respiratory Syncytial Virus Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Respiratory Syncytial Virus Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Respiratory Syncytial Virus Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

■ 보고서 목차

Table of Contents

1 Market Overview
1.1 Human Respiratory Syncytial Virus Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Approved Drugs
1.2.2 Off-Label Drugs
1.3 Market Analysis by Applications
1.3.1 Clinical Diagnostic
1.3.2 Laboratories Physicians’ Office
1.3.3 Laboratories Hospitals
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Human Respiratory Syncytial Virus Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Human Respiratory Syncytial Virus Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Human Respiratory Syncytial Virus Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical
2.4.1 Business Overview
2.4.2 Human Respiratory Syncytial Virus Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Respiratory Syncytial Virus Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Respiratory Syncytial Virus Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Respiratory Syncytial Virus Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Human Respiratory Syncytial Virus Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Respiratory Syncytial Virus Drugs Market Analysis by Regions
4.1 Global Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Human Respiratory Syncytial Virus Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
4.5 South America Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
5 North America Human Respiratory Syncytial Virus Drugs by Countries
5.1 North America Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
6 Europe Human Respiratory Syncytial Virus Drugs by Countries
6.1 Europe Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
6.3 UK Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
6.4 France Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Respiratory Syncytial Virus Drugs by Countries
7.1 Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
7.5 India Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
8 South America Human Respiratory Syncytial Virus Drugs by Countries
8.1 South America Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Respiratory Syncytial Virus Drugs by Countries
9.1 Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
10 Global Human Respiratory Syncytial Virus Drugs Market Segment by Type
10.1 Global Human Respiratory Syncytial Virus Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Respiratory Syncytial Virus Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2013-2018)
10.2 Approved Drugs Sales Growth and Price
10.2.1 Global Approved Drugs Sales Growth (2013-2018)
10.2.2 Global Approved Drugs Price (2013-2018)
10.3 Off-Label Drugs Sales Growth and Price
10.3.1 Global Off-Label Drugs Sales Growth (2013-2018)
10.3.2 Global Off-Label Drugs Price (2013-2018)
11 Global Human Respiratory Syncytial Virus Drugs Market Segment by Application
11.1 Global Human Respiratory Syncytial Virus Drugs Sales Market Share by Application (2013-2018)
11.2 Clinical Diagnostic Sales Growth (2013-2018)
11.3 Laboratories Physicians’ Office Sales Growth (2013-2018)
11.4 Laboratories Hospitals Sales Growth (2013-2018)
12 Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.1 Global Human Respiratory Syncytial Virus Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Respiratory Syncytial Virus Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.2.2 Europe Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.2.4 South America Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
12.3 Human Respiratory Syncytial Virus Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Human Respiratory Syncytial Virus Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Human Respiratory Syncytial Virus Drugs Market Share Forecast by Type (2018-2023)
12.4 Human Respiratory Syncytial Virus Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Human Respiratory Syncytial Virus Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Human Respiratory Syncytial Virus Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Human Respiratory Syncytial Virus Drugs Picture
Table Product Specifications of Human Respiratory Syncytial Virus Drugs
Figure Global Sales Market Share of Human Respiratory Syncytial Virus Drugs by Types in 2017
Table Human Respiratory Syncytial Virus Drugs Types for Major Manufacturers
Figure Approved Drugs Picture
Figure Off-Label Drugs Picture
Figure Human Respiratory Syncytial Virus Drugs Sales Market Share by Applications in 2017
Figure Clinical Diagnostic Picture
Figure Laboratories Physicians' Office Picture
Figure Laboratories Hospitals Picture
Figure United States Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Human Respiratory Syncytial Virus Drugs Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Human Respiratory Syncytial Virus Drugs Type and Applications
Table AstraZeneca Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Human Respiratory Syncytial Virus Drugs Type and Applications
Table AbbVie Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Human Respiratory Syncytial Virus Drugs Type and Applications
Table GSK Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Type and Applications
Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Respiratory Syncytial Virus Drugs Sales by Manufacturer (2016-2017)
Figure Global Human Respiratory Syncytial Virus Drugs Sales Market Share by Manufacturer in 2016
Figure Global Human Respiratory Syncytial Virus Drugs Sales Market Share by Manufacturer in 2017
Table Global Human Respiratory Syncytial Virus Drugs Revenue by Manufacturer (2016-2017)
Figure Global Human Respiratory Syncytial Virus Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Human Respiratory Syncytial Virus Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Human Respiratory Syncytial Virus Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Human Respiratory Syncytial Virus Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Global Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales by Regions (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales Market Share by Regions (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Revenue by Regions (2013-2018)
Figure Global Human Respiratory Syncytial Virus Drugs Revenue Market Share by Regions in 2013
Figure Global Human Respiratory Syncytial Virus Drugs Revenue Market Share by Regions in 2017
Figure North America Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Europe Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure South America Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure North America Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table North America Human Respiratory Syncytial Virus Drugs Sales by Countries (2013-2018)
Table North America Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries (2013-2018)
Figure North America Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries in 2013
Figure North America Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries in 2017
Table North America Human Respiratory Syncytial Virus Drugs Revenue by Countries (2013-2018)
Table North America Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2013
Figure North America Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2017
Figure United States Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Canada Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Europe Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table Europe Human Respiratory Syncytial Virus Drugs Sales by Countries (2013-2018)
Table Europe Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries (2013-2018)
Table Europe Human Respiratory Syncytial Virus Drugs Revenue by Countries (2013-2018)
Figure Europe Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2016
Figure Europe Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2017
Figure Germany Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure UK Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure France Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Russia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Italy Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Human Respiratory Syncytial Virus Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries 2017
Figure China Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Japan Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Korea Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure India Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure South America Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table South America Human Respiratory Syncytial Virus Drugs Sales by Countries (2013-2018)
Table South America Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries (2013-2018)
Figure South America Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries in 2017
Table South America Human Respiratory Syncytial Virus Drugs Revenue by Countries (2013-2018)
Table South America Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2017
Figure Brazil Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Respiratory Syncytial Virus Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Human Respiratory Syncytial Virus Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure UAE Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Human Respiratory Syncytial Virus Drugs Sales and Growth Rate (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales by Type (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales Share by Type (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Revenue by Type (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Revenue Share by Type (2013-2018)
Figure Global Approved Drugs Sales Growth (2013-2018)
Figure Global Approved Drugs Price (2013-2018)
Figure Global Off-Label Drugs Sales Growth (2013-2018)
Figure Global Off-Label Drugs Price (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales by Application (2013-2018)
Table Global Human Respiratory Syncytial Virus Drugs Sales Share by Application (2013-2018)
Figure Global Laboratories Physicians' Office Sales Growth (2013-2018)
Figure Global Laboratories Hospitals Sales Growth (2013-2018)
Figure Global Human Respiratory Syncytial Virus Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Sales Forecast by Regions (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
Figure Europe Sales Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
Figure South America Sales Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Human Respiratory Syncytial Virus Drugs Market Forecast (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Sales Forecast by Type (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Market Share Forecast by Type (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Sales Forecast by Application (2018-2023)
Table Global Human Respiratory Syncytial Virus Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
※본 조사보고서 [세계의 호흡기 융합 바이러스 (RSV) 치료제 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측] (코드 : GIR-AC0862) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 호흡기 융합 바이러스 (RSV) 치료제 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요.